Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

buy
BICO Group AB

Start price
Target price
Perf. (%)
€42.82
12.07.21
-
12.07.22
-64.97%
13.03.22

Kilianhammernick 
12.07.21 50%
buy
CD Projekt S.A.

Start price
Target price
Perf. (%)
€43.57
12.07.21
-
12.07.22
-22.34%
13.03.22

Kilianhammernick 
12.07.21 50%
buy
Aixtron SE

Start price
Target price
Perf. (%)
€21.42
12.07.21
-
12.07.22
-17.20%
13.03.22

Kilianhammernick 
12.07.21 50%
buy
Vectron Systems

Start price
Target price
Perf. (%)
€13.88
12.07.21
-
12.07.22
-62.18%
13.03.22

Kilianhammernick 
12.07.21 50%
buy
Nordex SE

Start price
Target price
Perf. (%)
€17.31
12.07.21
-
12.07.22
2.31%
13.03.22

Kilianhammernick 
12.07.21 50%
buy
Energiekontor

Start price
Target price
Perf. (%)
€59.00
12.07.21
-
12.07.22
40.17%
13.03.22

Kilianhammernick 
12.07.21 50%
buy
First Majestic Silver Corp.

Start price
Target price
Perf. (%)
€12.15
12.07.21
-
12.07.22
0.49%
13.03.22

Kilianhammernick 
12.07.21 50%
buy
Kontron AG

Start price
Target price
Perf. (%)
€20.86
12.07.21
-
12.07.22
-40.22%
13.03.22

Kilianhammernick 
12.07.21 50%
sell
Tempest Therapeutics Inc.

Start price
Target price
Perf. (%)
€28.25
12.07.21
-
12.07.22
-48.20%
15.07.21

Risky Investment
tinelchen 
12.07.21 0%
buy
SPI Energy Co Ltd ADR

Start price
Target price
Perf. (%)
€6.22
12.07.21
€9.00
12.07.22
-22.46%
24.07.21

Could be worthwhile Investment >10% per year
Good culture
Below average Marketposition
Few uniques
me8 
12.07.21 0%
sell
Tempest Therapeutics Inc.

Start price
Target price
Perf. (%)
€32.42
12.07.21
-
12.07.22
-92.41%
13.07.22

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
shadow 
12.07.21 0%
sell
Tempest Therapeutics Inc.

Start price
Target price
Perf. (%)
€35.61
12.07.21
€25.00
12.07.22
-50.33%
13.07.21

Capable Management
Good culture
No Innovation
Risky Investment
me8 
12.07.21 0%
sell
Curevac N.V.

Start price
Target price
Perf. (%)
€49.65
12.07.21
€1.00
12.07.22
-73.61%
13.07.22

Risky Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
kostojunior 
12.07.21 10%
buy
Bear Creek Mining Corp.

Start price
Target price
Perf. (%)
€1.08
12.07.21
-
12.07.22
14.10%
12.11.21

Could be worthwhile Investment >10% per year
robertinio 
12.07.21 100%
buy
Talga Gold Ltd

Start price
Target price
Perf. (%)
€0.80
11.07.21
€3.00
11.07.22
-8.75%
12.07.22

Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
Undervalued
positive Cash Flow expected
AlexKlar 
11.07.21 50%
sell
Sol

Start price
Target price
Perf. (%)
€17.64
11.07.21
€15.00
11.07.22
19.90%
26.11.21

Could be worthwhile Investment >10% per year
melinda 
11.07.21 50%
buy
Vapiano SE

Start price
Target price
Perf. (%)
€0.31
11.07.21
€0.75
11.07.22
-67.54%
12.07.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Innovative
Some uniques
AlexKlar 
11.07.21 50%
buy
Northern Data AG

Start price
Target price
Perf. (%)
€77.30
11.07.21
€180.00
11.07.22
26.78%
18.11.21

Could be worthwhile Investment >10% per year
Undervalued
Standard Investments for future growth
Normal challenges to pay loans and raise capital
AlexKlar 
11.07.21 50%
buy
Celtic

Start price
Target price
Perf. (%)
€1.27
11.07.21
€2.25
11.07.22
0.79%
12.07.22

Strong uniques
Stable Large shareholder and/or long term investor
Well known brand
Significant cyclical dependencies
AlexKlar 
11.07.21 50%
sell
Meta Material Inc.

Start price
Target price
Perf. (%)
€4.20
11.07.21
-
11.07.22
-76.45%
12.07.22

Probably not worthwhile Investment
Lokrim 
11.07.21 10%
buy
TAAT Global Alternatives Inc.

Start price
Target price
Perf. (%)
€2.10
11.07.21
€220.00
11.07.22
-57.00%
12.07.22

Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
High Investments for future growth
Undervalued
AlexKlar 
11.07.21 50%
buy
Ordina NV

Start price
Target price
Perf. (%)
€4.09
10.07.21
-
10.07.22
15.79%
11.07.22

Could be worthwhile Investment >10% per year
melinda 
10.07.21 0%
sell
Inovio Pharma

Start price
Target price
Perf. (%)
€6.92
10.07.21
€5.80
10.07.22
-6.86%
27.11.21

Very low/no dividend yield expected
Risky balance sheet
ROE lower than 10% per year
Increased challenges to pay loans and raise capital
geldnutzer 
10.07.21 50%
sell
CytoDyn Inc_INT

Start price
Target price
Perf. (%)
€1.28
10.07.21
€0.80
10.07.22
-30.80%
20.12.21

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Significant cyclical dependencies
geldnutzer 
10.07.21 50%
sell
Netlist Inc.

Start price
Target price
Perf. (%)
€5.19
10.07.21
-
10.07.22
35.26%
26.07.21

Probably not worthwhile Investment
Sievi 
10.07.21 0%